YOUCARE PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.96 CNY | -2.58% |
|
0.00% | -18.70% |
| 29/04 | Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 09/04 | Youcare Pharma Gets Nod for Registration of Gastric Drug | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 8,694 | 9,387 | 7,632 | - |
| Enterprise Value (EV) 1 | 8,694 | 9,387 | 7,632 | 7,632 |
| P/E ratio | 25.8 x | - | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 2.24 x | 1.71 x | 1.49 x |
| EV / Revenue | - | 2.24 x | 1.71 x | 1.49 x |
| EV / EBITDA | - | 23.3 x | 13.9 x | 10.5 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | 2.62 x | 1.96 x | 1.82 x |
| Nbr of stocks (in thousands) | 4,50,000 | 4,50,000 | 4,50,000 | - |
| Reference price 2 | 19.32 | 20.86 | 16.96 | 16.96 |
| Announcement Date | 27/02/23 | 24/02/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | 4,196 | 4,461 | 5,118 |
| EBITDA 1 | - | 402.1 | 551 | 725 |
| EBIT 1 | - | 231.8 | 383 | 537 |
| Operating Margin | - | 5.52% | 8.59% | 10.49% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | 337.8 | - | - | - |
| Net margin | - | - | - | - |
| EPS | 0.7500 | - | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 27/02/23 | 24/02/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 4.85% | 8.1% | 10.6% |
| ROA (Net income/ Total Assets) | - | 3.16% | 5.2% | 6.9% |
| Assets | - | - | - | - |
| Book Value Per Share 1 | - | 7.970 | 8.670 | 9.310 |
| Cash Flow per Share | - | - | - | - |
| Capex 2 | - | 495 | 341 | 277 |
| Capex / Sales | - | 11.8% | 7.64% | 5.41% |
| Announcement Date | 27/02/23 | 24/02/24 | - | - |
1CNY2CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.96
CNY
Average target price
28
CNY
Spread / Average Target
+65.09%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.70% | 105.41Cr | |
| +16.93% | 7.94TCr | |
| +9.28% | 873.65Cr | |
| -14.24% | 493.63Cr | |
| +49.95% | 470.43Cr | |
| +5.96% | 397.8Cr | |
| +11.81% | 227.56Cr | |
| -23.57% | 227.72Cr | |
| +17.77% | 213.57Cr | |
| -32.28% | 212.07Cr |
- Stock Market
- Equities
- 688658 Stock
- Financials Youcare Pharmaceutical Group Co., Ltd.
